Cardiotoxicity and cancer therapy

Angiology

Volumn 65, Issue 5, 2014, Pages 369-371

  Vasiliadis, I ^a,b   Kolovou, G ^b   Mikhailidis, D P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; AXITINIB; BEVACIZUMAB; ESTROGEN RECEPTOR; FLUOROURACIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PAZOPANIB; PROCOAGULANT; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; TAMOXIFEN; TOREMIFENE; VANDETANIB; VASCULOTROPIN; VASODILATOR AGENT;

ACUTE PANCREATITIS; ATHEROSCLEROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CHOLESTEROL BLOOD LEVEL; EDITORIAL; ENDOCARDIUM; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE NECROSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTENSION; ISCHEMIC HEART DISEASE; MONOCYTE; OCCLUSION; PERICARDIAL DISEASE; PERICARDITIS; QT PROLONGATION; TAKOTSUBO CARDIOMYOPATHY; THROMBOEMBOLISM; VASOSPASM;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CAROTID STENOSIS; CORONARY DISEASE; FIBROSIS; HEART; HEART CONDUCTION SYSTEM; HEART DISEASES; HUMANS; MYOCARDIUM; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; VASCULAR STIFFNESS;

EID: 84899020315     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713498298     Document Type: Editorial

References (27)

1. Davis M, Witteles RM. Cardiac testing to manage cardiovascular risk in cancer patients. Semin Oncol. 2013 ; 40 (2). 147-155
2. Berardi R, Caramanti M, Savini A, et al Crit Rev Oncol Hematol. 2013:
3. Sorrentino MF, Kim J, Foderaro AE. Truesdell AG. 5-Fluorouracil induced cardiotoxicity: review of the literature. Cardiol J. 2012 ; 19 (5). 453-458
4. Ozturk MA, Ozveren O, Cinar V, Erdik B, Oyan B. Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood Coagul Fibrinolysis. 2013 ; 24 (1). 90-94
5. Mikhailidis DP, Gillett DS, Lang-Stevenson D.. Fluorouracil cardiotoxicity. Br Med J. 1978 ; 1 (6120). 1138 (Pubitemid 8319317)
6. Simbre VC, Duffy SA, Dadlani GH, Miller TL, Lipshultz SE. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr Drugs. 2005 ; 7 (3). 187-202 (Pubitemid 41019943)
7. Outomuro D, Grana DR, Azzato F, Milei J. Adriamycin-induced myocardial toxicity: new solutions for an old problem?. Int J Cardiol. 2007 ; 117 (1). 6-15 (Pubitemid 46399979)
8. Kubota Y. Tumor angiogenesis and anti-angiogenic therapy. Keio J Med. 2012 ; 61 (2). 47-56
9. Khorana AA. Cancer and coagulation. Am J Hematol. 2012 ; 87 (suppl 1). S82 - S87
10. Filippatos TD, Liberopoulos EN, Pavlidis N, Elisaf MS, Mikhailidis DP. Effects of hormonal treatment on lipids in patients with cancer. Cancer Treat Rev. 2009 ; 35 (2). 175-184
11. Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011 ; 103 (17). 1299-1309
12. Smith MR, Malkowicz SB, Chu F, et al. Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study. J Clin Oncol. 2008 ; 26 (11). 1824-1829
13. Martinou M, Gaya A. Cardiac complications after radical radiotherapy. Semin Oncol. 2013 ; 40 (2). 178-185
14. Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012 ; 33 (13). 1635-1701
15. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007 ; 99 (5). 365-375 (Pubitemid 47073480)
16. Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013 ; 61 (23). 2319-2328
17. Copeland KA, Hosmane VR, Jurkovitz C, et al. Frequency of severe valvular disease caused by mediastinal radiation among patients undergoing valve surgery in a community-based, regional academic medical center. Clin Cardiol. 2013 ; 36 (4). 217-221
18. Smith GL, Smith BD, Buchholz TA, et al. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008 ; 26 (31). 5119-5125
19. Paraskevas KI, Giannoukas AD, Mikhailidis DP. Irradiation-induced carotid artery stenosis: a preventable complication of neck radiotherapy?. Angiology. 2009 ; 60 (3). 273-275
20. Kilicaslan B, Piskin GD, Susam I, Dursun H, Ozdogan O Angiology. 2013:
21. Paraskevas KI, Mikhailidis DP, Veith FJ.. Patients with peripheral arterial disease, abdominal aortic aneurysms and carotid artery stenosis are at increased risk for developing lung and other cancers. Int Angiol. 2012 ; 31 (4). 404-405
22. Bosch X, Rovira M, Sitges M, et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME Trial (prevention of left ventricular dysfunction with enalapril and caRvedilol in patients submitted to intensive chemotherapy for the treatment of malignanthemopathies). J Am Coll Cardiol. 2013 ; 61 (23). 2355-2362
23. Boyle P, Boniol M, Koechlin A, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012 ; 107 (9). 1608-1617
24. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012 ; 35 (11). 2402-2411
25. Singh S, Singh PP. Statin a day keeps cancer at bay. World J Clin Oncol. 2013 ; 4 (2). 43-46
26. Kostapanos MS, Elisaf MS, Mikhailidis DP Curr Pharm Des. 2012:
27. Smiseth OA, Edvardsen T, Skulstad H. Cardioprotection during chemotherapy. J Am Coll Cardiol. 2013 ; 61 (23). 2363-2364